All In Biotech

Drug Trial Radar · NCT02205931

Ketogenic Diet in Infants With Epilepsy (KIWE)

A Randomised Controlled Trial of the Ketogenic Diet in the Treatment of Epilepsy in Children Under the Age of Two Years

Last checked: Nov 19, 2026Latest source record: May 4, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

160

Planned (sponsor's estimate)

Start

Jan 2015

Primary completion

Jun 2018

Study completion Jun 2019

Sponsor

Lead sponsor
University College, LondonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Great Ormond Street Hospital for Children NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Bristol Royal Hospital for Children; Birmingham Women's and Children's NHS Foundation Trust; The Leeds Teaching Hospitals NHS Trust; Manchester University NHS Foundation Trust; Sheffield Children's NHS Foundation Trust; National Institute for Health Research, United Kingdom; Lancashire Care NHS Foundation Trust; Newcastle-upon-Tyne Hospitals NHS Trust; St George's University Hospitals NHS Foundation Trust
First posted
Aug 1, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 1 month, up to 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Epilepsy, a condition where individuals are prone to recurrent epileptic seizures, is the most common chronic neurological disorder in children. Epilepsy onset is most common in the first two years of life and is associated with poor prognosis for seizure control and neurodevelopmental outcome. The ketogenic diet (KD) is a medically supervised diet that is high in fat and restricted in carbohydrates and protein. KD therapy has shown to be an effective treatment for seizures in children with epilepsy older than two. Associated benefits include: a reduced requirement for routine and emergency antiepileptic drugs (AED) and fewer seizure related hospital admissions. Although reports suggest that KD therapy improves seizures in younger children there is no high quality trial data that demonstrates effectiveness and safety in this age group. The KD is resource intensive, requiring dietetic and physician time; data is required to justify expansion of services to cater for the apparent need. The investigators therefore propose a prospective multicentre randomised trial to investigate the effectiveness and safety of the KD in children with epilepsy under the age of 2, who have failed to respond to two or more AEDs. Children will be randomly assigned to either receive the KD or further AEDs. The allocated treatment will be started after a 2week baseline period, and it's effectiveness assessed after 8 weeks. Seizure diaries will be used to record seizures and related events, a questionnaire will be used to assess diet tolerance; also growth and blood biochemistry will be monitored. The information obtained from this study is necessary to optimise choices in epilepsy treatment, aiming to improve outcomes and thus determine whether and when the KD should should be used.

Conditions

  • Epilepsy

Interventions

  • Ketogenic dietOther

    The ketogenic diet is a high fat diet designed to mimic the effects on the body of starvation. The premise is the main energy intake is fat, which is utilised in the body and produces ketones.

  • Antiepileptic drug therapyDrug

    The control intervention will be drug therapy with the most appropriate further antiepileptic drug for a particular child, depending on their presenting seizures and syndrome and previous drugs used, and chosen by the expert clinician responsible for management of the patient's epilepsy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of seizuresTime frame: 6 - 8 weeks

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Children's Hospital

    Birmingham, United Kingdom · Recruiting

  • Bristol Royal Hospital for Children

    Bristol, United Kingdom · Recruiting

  • Addenbrooke's Hospital

    Cambridge, United Kingdom · Recruiting

  • Lancashire Teaching Hospitals NHS Foundation Trust

    Lancashire, United Kingdom · Recruiting

  • Leeds Teaching Hospital

    Leeds, United Kingdom · Recruiting

  • Alder Hey Children's Hospital

    Liverpool, United Kingdom · Recruiting

  • Great Ormond Street Hospital

    London, United Kingdom · Recruiting

  • St George's University Hospitals NHS Foundation Trust

    London, United Kingdom · Recruiting

  • Royal Manchester Children's Hospital

    Manchester, United Kingdom · Recruiting

  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust

    Newcastle upon Tyne, United Kingdom · Recruiting

  • Sheffield Children's NHS Foundation Trust

    Sheffield, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.